These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11716960)

  • 1. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components with potential immunosuppressive activity in lipopolysaccharide of laboratory Pseudomonas aeruginosa strains.
    Vikström EV
    Immunol Lett; 2003 Jan; 85(1):29-33. PubMed ID: 12505193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunobiological properties of the lipopolysaccharides of bacteria in the genus Shigella with contrasting virulence and their chemically modified analogs].
    Borisova EV
    Mikrobiol Z; 1999; 61(4):64-71. PubMed ID: 10565153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the structural parts of bacterial lipopolysaccharide in its direct immunosuppressive activity].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):22-5. PubMed ID: 10356729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive components of extracellular polysaccharide from Pseudomonas aeruginosa clinical strains].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):35-8. PubMed ID: 11210632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipopolysaccharide changes in smooth-type avirulent Shigella in comparison with initial virulent strains].
    Nikolaeva AI; Nastichkin IA; Kabanova EA; Lapina EB; Krukovets IL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):15-8. PubMed ID: 1441805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunosuppressive activity of filtrates of the culture broth from nonvirulent salmonellae].
    Molozhavaia OS; Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(2):73-8. PubMed ID: 9221061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunosuppressive activity of Shigella sonnei differing by the presence of plasmid pSS120].
    Borisova EV; Bondarenko VM; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):65-8. PubMed ID: 9460870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive action of lipopolysaccharide S- and R-forms of Salmonella and the role of lipid A].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):20-3. PubMed ID: 9949494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Separation of Shigella enterotoxin and immunosuppression factors].
    Borisov VA
    Mikrobiol Zh (1978); 1988; 50(1):77-80. PubMed ID: 3074243
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunosuppressive activity of Streptococcus aureus peptidoglycan].
    Posur VK; Borisova EV; Furtat IM; Lolo AA; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):56-8. PubMed ID: 7778377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation of the immunosuppressivity of virulent Shigella to the structure of O antigen].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):63-7. PubMed ID: 2452538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [O-specific L-hapten in the composition of Shigella sonnei].
    Egorova TP; Sazykina SIu; Fedosova VG; Lebenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):8-13. PubMed ID: 2482642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon induction in mice by uniform salt forms of Shigella sonnei lipopolysaccharide and its components.
    Lugowski C; Błach-Olszewska Z; Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):513-6. PubMed ID: 373682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The molecular heterogeneity of Shigella sonnei lipopolysaccharide based on polyacrylamide gel electrophoretic data].
    Nartikova VF; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):10-4. PubMed ID: 2251881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.